CVS Health Corporation
CVS
$66.97
-$0.88-1.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.84% | -19.65% | -96.15% | -6.89% | -47.89% |
| Total Depreciation and Amortization | 1.41% | 1.15% | 3.02% | 4.26% | 13.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 384.06% | -335.53% | 543.33% | -95.30% | -126.14% |
| Change in Net Operating Assets | -47.56% | 93.48% | -225.00% | -94.15% | -32.60% |
| Cash from Operations | -7.08% | 170.56% | -127.43% | -47.71% | -34.08% |
| Capital Expenditure | -5.39% | 15.70% | -22.94% | -7.95% | 28.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 20.00% | 91.67% | 33.33% | 99.49% | 99.65% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.07% | 209.48% | -1,181.25% | -140.15% | -212.84% |
| Cash from Investing | 63.61% | 55.96% | -334.11% | 84.32% | 75.41% |
| Total Debt Issued | -- | 2,036.50% | 160.00% | -77.71% | -57.67% |
| Total Debt Repaid | -8,800.00% | -609.95% | -55.12% | 96.59% | 95.03% |
| Issuance of Common Stock | -29.06% | -45.71% | -6.56% | 4.17% | 111.46% |
| Repurchase of Common Stock | 99.64% | 20.00% | 0.00% | -7.58% | -49.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -7.57% | -7.45% | -7.92% | -7.83% |
| Other Financing Activities | 30.30% | 433.33% | 108.99% | -57.14% | 74.22% |
| Cash from Financing | -90.06% | 144.34% | 41.12% | -65.55% | -145.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.59% | 135.96% | -655.32% | 427.66% | -4.12% |